Khan Najat

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Khan Najat's trades of Recursion Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-05
PlS Planned sale
59,898 +25.3%
289.64
US$291,084 		59,898 +25.3% 289.64 US$291,084
2026-06-05 2026-06-05
PlS Planned sale
12,514 -41.9%
386.29
US$662,222 		12,514 -41.9% 386.29 US$662,222
2026-06-05 2026-06-05
PrS Proposed sale
50,237
194.92
US$493,829 		50,237 194.92 US$493,829
2026-03-11 2026-03-09
PlS Planned sale
28,298 -1.2%
3.35
US$94,660 		28,298 -1.2% 3.35 US$94,660
2026-03-09 2026-03-09
PrS Proposed sale
28,298
3.35
US$94,662 		28,298 3.35 US$94,662
2025-12-29 2025-12-22
PlS Planned sale
124,403 -16.9%
4.41
US$548,592 		124,403 -16.9% 4.41 US$548,592
2025-12-22 2025-12-22
PrS Proposed sale
124,403
4.41
US$548,588 		124,403 4.41 US$548,588
2025-08-19 2025-08-18
S Sale
36,599 -5.2%
5.52
US$202,173 		36,599 -5.2% 5.52 US$202,173
2025-08-18 2025-08-18
PrS Proposed sale
36,599
5.52
US$202,169 		36,599 5.52 US$202,169